Company profile
Utah Medical Products, Inc.
NASDAQ: UTMD · Healthcare · Medical - Instruments & Supplies
#473 of 1,418 Healthcare companies by revenuetop-decile growth
EA Score
80B+FH 94DQ 68GM 67SS 75
v0.1 · 65/100 weight · provisional
↑ balance-sheet leverage, Altman-Z · ↓ growth stability, filing timeliness
Methodology →Revenue TTM
$36.1M
Rev growth YoY (TTM)
-7.0%
Net income (FY)
$11.3M
Employees
146
as of 2026-08-13
Market cap
$229.7M
as of 2026-08-13
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$38.5M$38.5M2025
Net income$11.3M$11.3M2025
Operating income$11.4M$11.4M2025
Total assets$122.5M$122.5M2025
Liabilities$3.3M$3.3M2025
Equity$119.3M$119.3M2025
Revenue trend
FY2024 – FY2025 · USD
FY24
FY24
FY24
FY24
FY25
FY25
FY25
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Utah Medical Products, Inc.’s revenue?
Utah Medical Products, Inc. booked $38.5M in FY2025 revenue, growing 293% year over year — faster than 91% of Healthcare companies we track, at a 29.3% net margin.
Peers · Healthcare
Kymera Therapeutics, Inc.53DInterpace Biosciences, Inc.74BPalvella Therapeutics, Inc.54DRetractable Technologies, Inc.57CCytosorbents Corporation55CClearPoint Neuro, Inc.62CNeighbors
Salt Lake →Key facts
CEOKevin L. Cornwell
SectorHealthcare
IndustryMedical - Instruments & Supplies
HeadquartersMidvale, UT
ExchangeNASDAQ: UTMD
Employees146
IPO date1999-03-08
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.